The board of directors of UMP Healthcare Holdings Limited announced that, based on the information currently available to the Board and the preliminary review of the unaudited management accounts of the Group, the Board expects that the net profit of the Company for the year ended 30 June 2019 will represent a significant decrease of approximately 55% as compared with the corresponding period for the year ended 30 June 2018. Such decrease is mainly attributable to the non-cash expense of a total of HKD 48 million incurred in connection with the granting of certain numbers of share options under the Post-IPO Share Option Scheme adopted by the Company on 2 November 2015 and the issuance of an aggregate of 110,411,000 Warrants and the vesting of 36,803,667 Warrants of the Company to Zheng He on 6 December 2018.